Trombly Amy Moss 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 8, 2021
Insider Transaction Report
Form 4
Trombly Amy Moss
Chief Executive Officer
Transactions
- Award
Stock option (right to buy)
2021-01-07+27,777→ 43,648 totalExercise: $8.03Exp: 2031-01-07→ Common Stock (27,777 underlying)
Footnotes (2)
- [F1]The options vest one third each on 01/07/2022, 01/07/2023 and 01/07/2024, or upon change of control.
- [F2]The options were awarded and granted to Ms. Trombly for services performed.